Scientists call for more multi-arm clinical trials to speed up approval of new drugsBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4812 (Published 25 July 2014) Cite this as: BMJ 2014;349:g4812
- Adrian O’Dowd
Experts have called for more multi-arm clinical trials instead of the traditional two arm studies, to allow new drugs to reach patients more quickly and to save money.
Academics from the Medical Research Council’s clinical trials unit have recommended a change in approach to trials, in a commentary published online in the Lancet on 25 July.1 Traditionally, researchers carry out a two arm study—where one treatment is compared with another—rather than doing a multi-arm trial, where several …
Log in using your username and password
Log in through your institution
Sign up for a free trial